Floatz logo

Tirzepatide

Adult Congenital Heart Disease

University Medical Centre Ljubljanaprotein_peptidePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Adult Congenital Heart Disease cohort.

Asset / SponsorPhaseRating
Dolutegravir
Augusta University
Phase 4BB
Sildenafil
Mayo Clinic
Phase 3B
CARVEDILOL
Northwestern University
Phase 2CCC
Fibrinogen Concentrate Human
IRCCS Policlinico S. Donato
Phase 2CCC
Prothrombin Complex Concentrate, Human
IRCCS Policlinico S. Donato
Phase 2CCC

View all 10 →

Same molecule, other indications

Tirzepatide is also rated in:

type 1 diabetes mellitusDormant
BBB
Indicative ·
78 / 100
View asset →
psoriatic arthritisDormant
BBB
Indicative ·
74 / 100
View asset →
diastolic heart failureDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →